Status:
COMPLETED
Interdisciplinary Approach for Refractory Dyspnoea
Lead Sponsor:
Ligue Pulmonaire Neuchâteloise
Conditions:
Dyspnea
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Dyspnoea is a very common symptom in many diseases, not only cardiorespiratory, but also renal or neurological diseases. It can be defined as " difficult, laboured and uncomfortable breathing \[…\]. I...
Detailed Description
The dyspnoea support program will include 4 steps: Step 1: Initial interview Before the initial interview, the responsible physician will review or examine the medical records via the request sheet s...
Eligibility Criteria
Inclusion
- refractory breathlessness on exertion or rest (Medical Research Council (MRC) dyspnea scale score ≥2), despite optimum treatment of the underlying disease, as deemed by the responsible physician;
- advanced disease such as cancer, chronic obstructive pulmonary disease (COPD), chronic heart failure, interstitial lung disease or motor neuron disease;
- willing to engage with proposed therapy (physiotherapy);
- able to provide informed consent in French.
Exclusion
- Breathlessness of unknown cause;
- A primary diagnosis of chronic hyperventilation syndrome;
- Completely house (or hospital or nursing home) bound
Key Trial Info
Start Date :
August 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2022
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT04015817
Start Date
August 1 2019
End Date
June 1 2022
Last Update
July 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ligue pulmonaire neuchâteloise
Peseux, Canton of Neuchâtel, Switzerland, 2034